Stay updated on Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial
Sign up to get notified when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.

Latest updates to the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new results posting entry dated 2026-05-12 was added for FORSYYN, including the Results Posted label and a detailed description of the study duration (30 weeks), phases (screening/run-in, randomization, treatment, follow-up), and the visit schedule and outcomes. Older 2024-era results-submission text and related eligibility/endpoints were removed.SummaryDifference6%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThis update changes the page revision identifier from v3.5.2 to v3.5.3, reflecting a site/version maintenance change rather than new study information.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No observable changes to study details.SummaryDifference0.0%

- Check52 days agoChange DetectedNew publication entry added under Publications for the FORSYYN study, detailing results of the CHF 1535 pMDI versus Symbicort COPD trial.SummaryDifference0.0%

- Check67 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foster® pMDI vs Symbicort® Turbohaler in COPD Patient Clinical Trial page.